CV/COS Webinar: Clip 1

At Carevive, our mission is to build patient-centric programs and therapies that revolutionize cancer care. Central to our approach is gaining a comprehensive understanding of how patients experience the disease and navigate different stages of therapy and care. This is where Carevive’s data platform comes into play, offering a unique opportunity to delve into the patient journey.

Our platform allows us to study patients with early-stage disease, a prime example being breast cancer, as Dr. Aaron will discuss in this video. However, our commitment to advancing cancer care extends beyond breast cancer to encompass various solid tumors and liquid cancers.

Through the wealth of data we gather and analyze, we gain invaluable insights into patient experiences, treatment outcomes, and care pathways. By harnessing the power of data, we pave the way for more targeted and effective interventions, leading to better outcomes and improved quality of life for cancer patients.

Stay tuned as we continue to unravel the intricate patient journey through data-driven research, bringing us closer to a future where cancer care is truly patient-centric and personalized. Together, we are forging a path towards a brighter future for cancer patients and their families.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…